The Cost of Treatment of Alzheimer's Disease in The Netherlands: A Regression-Based Simulation Model

Author： McDonnell J.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.19, Iss.4, 2001-04, pp. : 379-390

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Markov Model of the Cost Effectiveness of Olanzapine Treatment for Agitation and Psychosis in Alzheimer's Disease

By Kirbach Stephanie  

Clinical Drug Investigation, Vol. 28, Iss. 5, 2008-01 ,pp. : 291-303

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Donepezil in the Treatment of Mild to Moderate Alzheimer's Disease: A UK Evaluation Using Discrete-Event Simulation

By Getsios Denis  

PharmacoEconomics, Vol. 28, Iss. 5, 2010-05 ,pp. : 411-427

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Memantine in Alzheimer’s Disease: An Analysis Based on a Probabilistic Markov Model from a UK Perspective

By Roy W. Jones  

Drugs & Aging, Vol. 21, Iss. 9, 2004-01 ,pp. : 607-620

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Cholinesterase Inhibitors in the Treatment of Alzheimer's Disease: A Review with Methodological Considerations

By Wimo A.  

Drugs & Aging, Vol. 21, Iss. 5, 2004-01 ,pp. : 279-295

Adis International

Access to resources Recommend Favorite

Potential Savings in the Cost of Caring for Alzheimer's Disease: Treatment with Rivastigmine

By Brett Hauber A.  

PharmacoEconomics, Vol. 17, Iss. 4, 2000-04 ,pp. : 351-360

Adis International

Access to resources Recommend Favorite